K. Kessler, H. Coleman, S. Hossack, M. Dunn, R. Habaradas, J. Shin, P. Sista
{"title":"一项1期、开放标签、随机、单剂量、重复、交叉研究,以评估艾苏伯前列素钾片和艾苏伯前列素钠片在健康受试者中的生物等效性","authors":"K. Kessler, H. Coleman, S. Hossack, M. Dunn, R. Habaradas, J. Shin, P. Sista","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5070","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":120238,"journal":{"name":"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH","volume":"52 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Phase 1, Open-Label, Randomized, Single Dose, Replicate Four-Way, Crossover Study to Assess the Bioequivalence of Esuberaprost Potassium Tablets and Esuberaprost Sodium Tablets in Healthy Subjects\",\"authors\":\"K. Kessler, H. Coleman, S. Hossack, M. Dunn, R. Habaradas, J. Shin, P. Sista\",\"doi\":\"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5070\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":120238,\"journal\":{\"name\":\"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH\",\"volume\":\"52 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5070\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C51. CLOSER TO THE HEART: UPDATE ON APPROVED THERAPIES FOR PAH","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5070","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A Phase 1, Open-Label, Randomized, Single Dose, Replicate Four-Way, Crossover Study to Assess the Bioequivalence of Esuberaprost Potassium Tablets and Esuberaprost Sodium Tablets in Healthy Subjects